Regulation of myocardial matrix metalloproteinase expression and activity by cardiac fibroblasts

IUBMB Life

Volumn 64, Issue 2, 2012, Pages 143-150

  Turner, Neil A ^a   Porter, Karen E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

cardiac fibroblast; cytokines; extracellular matrix; growth factors; matrix metalloproteinase; myocardium; remodeling; signal transduction; transcription

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; STROMELYSIN;

CARDIOMYOPATHY; ENZYME ACTIVITY; ENZYME REGULATION; FIBROBLAST; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

ANIMALS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; MATRIX METALLOPROTEINASES, SECRETED; MYOCARDIUM; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84855871250     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.594     Document Type: Review

References (54)

1. Cohn, J. N., Ferrari, R., and, Sharpe, N., (2000) Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J. Am. Coll. Cardiol. 35, 569-582. (Pubitemid 30167013)
2. Porter, K. E., and, Turner, N. A., (2009) Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 123, 255-278.
3. Turner, N. A., ed. (2011) The Cardiac Fibroblast. Research Signpost, Kerala, India.
4. Brower, G. L., Gardner, J. D., Forman, M. F., Murray, D. B., Voloshenyuk, T., et al. (2006) The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur. J. Cardiothorac. Surg. 30, 604-610. (Pubitemid 44332949)
5. Spinale, F. G., (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev. 87, 1285-1342. (Pubitemid 350041472)
6. van den Borne, S. W., Diez, J., Blankesteijn, W. M., Verjans, J., Hofstra, L., et al. (2010) Myocardial remodeling after infarction: the role of myofibroblasts. Nat. Rev. Cardiol. 7, 30-37.
7. Lindsey, M. L., and, Zamilpa, R., (2011) Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc. Ther., in press. Doi:10.1111/j.1755-5922.2010.00207.x.
8. Rodriguez, D., Morrison, C. J., and, Overall, C. M., (2010) Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim. Biophys. Acta 1803, 39-54.
9. Nagase, H., Visse, R., and, Murphy, G., (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69, 562-573. (Pubitemid 43139720)
10. Kandasamy, A. D., Chow, A. K., Ali, M. A., and, Schulz, R., (2010) Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc. Res. 85, 413-423.
11. Cleutjens, J. P., Kandala, J. C., Guarda, E., Guntaka, R. V., and, Weber, K. T., (1995) Regulation of collagen degradation in the rat myocardium after infarction. J. Mol. Cell Cardiol. 27, 1281-1292.
12. Mukherjee, R., Mingoia, J. T., Bruce, J. A., Austin, J. S., Stroud, R. E., et al. (2006) Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction. Am. J. Physiol Heart Circ. Physiol 291, H2216-H2228.
13. Turner, N. A., Warburton, P., O'Regan, D. J., Ball, S. G., and, Porter, K. E., (2010) Modulatory effect of interleukin-1a on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: role of p38 MAP kinase. Matrix Biol. 29, 613-620.
14. Wei, Y., Cui, C., Lainscak, M., Zhang, X., Li, J., et al. (2011) Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling. J. Cell Mol. Med. 15, 773-782.
15. Lindsey, M. L., Escobar, G. P., Mukherjee, R., Goshorn, D. K., Sheats, N. J., et al. (2006) Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation 113, 2919-2928. (Pubitemid 44297233)
16. van den Borne, S. W., Cleutjens, J. P., Hanemaaijer, R., Creemers, E. E., Smits, J. F., et al. (2009) Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc. Pathol. 18, 37-43.
17. Cortez, D. M., Feldman, M. D., Mummidi, S., Valente, A. J., Steffensen, B., et al. (2007) IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-b, NF-kB, and AP-1 activation. Am. J. Physiol Heart Circ. Physiol 293, H3356-H3365. (Pubitemid 350230876)
18. Riches, K., Morley, M. E., Turner, N. A., O'Regan, D. J., Ball, S. G., et al. (2009) Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts. J. Mol. Cell Cardiol. 47, 391-399.
19. Roy, S., Khanna, S., Hussain, S. R., Biswas, S., Azad, A., et al. (2009) MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res. 82, 21-29.
20. Guo, D., Kassiri, Z., Basu, R., Chow, F. L., Kandalam, V., et al. (2010) Loss of PI3Kg enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress. Circ. Res. 107, 1275-1289.
21. Schram, K., Ganguly, R., No, E. K., Fang, X., Thong, F. S., et al. (2011) Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration. Endocrinology 152, 2037-2047.
22. Vincenti, M. P., and, Brinckerhoff, C. E., (2007) Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you? J. Cell Physiol 213, 355-364. (Pubitemid 47509713)
23. Yan, C., and, Boyd, D. D., (2007) Regulation of matrix metalloproteinase gene expression. J. Cell Physiol 211, 19-26. (Pubitemid 46363892)
24. Awad, A. E., Kandalam, V., Chakrabarti, S., Wang, X., Penninger, J. M., et al. (2010) Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kg-dependent manner. Am. J. Physiol Cell Physiol 298, C679-C692.
25. Vanhoutte, D., Schellings, M., Pinto, Y., and, Heymans, S., (2006) Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc. Res. 69, 604-613. (Pubitemid 43139724)
26. Li, Y. Y., McTiernan, C. F., and, Feldman, A. M., (1999) Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. Cardiovasc. Res. 42, 162-172. (Pubitemid 29167081)
27. Balbin, M., Fueyo, A., Knauper, V., Lopez, J. M., Alvarez, J., et al. (2001) Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J. Biol. Chem. 276, 10253-10262.
28. Foronjy, R. F., Sun, J., Lemaitre, V., and, D'Armiento, J. M., (2008) Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model. Hypertens. Res. 31, 725-735. (Pubitemid 351772864)
29. Kim, H. E., Dalal, S. S., Young, E., Legato, M. J., Weisfeldt, M. L., et al. (2000) Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J. Clin. Invest 106, 857-866.
30. Lindsey, M. L., Gannon, J., Aikawa, M., Schoen, F. J., Rabkin, E., et al. (2002) Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation 105, 753-758. (Pubitemid 34157381)
31. Yarbrough, W. M., Mukherjee, R., Escobar, G. P., Mingoia, J. T., Sample, J. A., et al. (2003) Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling. Circulation 108, 1753-1759. (Pubitemid 37243666)
32. Hudson, M. P., Armstrong, P. W., Ruzyllo, W., Brum, J., Cusmano, L., et al. (2006) Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. J. Am. Coll. Cardiol. 48, 15-20. (Pubitemid 43929218)
33. Rosenkranz, S., (2004) TGF-b1 and angiotensin networking in cardiac remodeling. Cardiovasc. Res. 63, 423-432. (Pubitemid 38970186)
34. White, L. A., Mitchell, T. I., and, Brinckerhoff, C. E., (2000) Transforming growth factor b inhibitory element in the rabbit matrix metalloproteinase-1 (collagenase-1) gene functions as a repressor of constitutive transcription. Biochim. Biophys. Acta 1490, 259-268. (Pubitemid 30103799)
35. Fahling, M., Perlewitz, A., Doller, A., and, Thiele, B. J., (2004) Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia. Comp Biochem. Physiol C. Toxicol. Pharmacol. 139, 119-126. (Pubitemid 39535795)
36. Small, E. M., and, Olson, E. N., (2011) Pervasive roles of microRNAs in cardiovascular biology. Nature 469, 336-342.
37. Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984.
38. Patrick, D. M., Montgomery, R. L., Qi, X., Obad, S., Kauppinen, S., et al. (2010) Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Invest 120, 3912-3916.
39. Turner, N. A., Aley, P. K., Hall, K. T., Warburton, P., Galloway, S., et al. (2007) Simvastatin inhibits TNFa-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms. J. Mol. Cell Cardiol. 43, 168-176. (Pubitemid 47069380)
40. Xie, Z., Singh, M., and, Singh, K., (2004) Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1b. J. Biol. Chem. 279, 39513-39519. (Pubitemid 39258218)
41. Brown, R. D., Jones, G. M., Laird, R. E., Hudson, P., and, Long, C. S., (2007) Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. Biochem. Biophys. Res. Commun. 362, 200-205. (Pubitemid 47304407)
42. Mukherjee, R., Bruce, J. A., McClister, D. M., Jr., Allen, C. M., Sweterlitsch, S. E., et al. (2005) Time-dependent changes in myocardial structure following discrete injury in mice deficient of matrix metalloproteinase-3. J. Mol. Cell Cardiol. 39, 259-268. (Pubitemid 40995015)
43. Barbolina, M. V., and, Stack, M. S., (2008) Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. Semin. Cell Dev. Biol. 19, 24-33. (Pubitemid 350245611)
44. Gingras, D., and, Beliveau, R., (2010) Emerging concepts in the regulation of membrane-type 1 matrix metalloproteinase activity. Biochim. Biophys. Acta 1803, 142-150.
45. Spruill, L. S., Lowry, A. S., Stroud, R. E., Squires, C. E., Mains, I. M., et al. (2007) Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy. Am. J. Physiol Cell Physiol 293, C1362-C1373. (Pubitemid 47556744)
46. Deschamps, A. M., Yarbrough, W. M., Squires, C. E., Allen, R. A., McClister, D. M., et al. (2005) Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity. Circulation 111, 1166-1174. (Pubitemid 40365479)
47. Spinale, F. G., Mukherjee, R., Zavadzkas, J. A., Koval, C. N., Bouges, S., et al. (2010) Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction. J. Biol. Chem. 285, 30316-30327.
48. Zavadzkas, J. A., Mukherjee, R., Rivers, W. T., Patel, R. K., Meyer, E. C., et al. (2011) Direct regulation of membrane type-1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function and remodeling. Am. J. Physiol Heart Circ. Physiol 301, H1656-H1666.
49. Stawowy, P., Margeta, C., Kallisch, H., Seidah, N. G., Chretien, M., et al. (2004) Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-b1 involves furin-convertase. Cardiovasc. Res. 63, 87-97. (Pubitemid 38759813)
50. Guo, C., and, Piacentini, L., (2003) Type I collagen-induced MMP-2 activation coincides with up-regulation of membrane type 1-matrix metalloproteinase and TIMP-2 in cardiac fibroblasts. J. Biol. Chem. 278, 46699-46708. (Pubitemid 37452248)
51. Yana, I., and, Weiss, S. J., (2000) Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol. Biol. Cell 11, 2387-2401. (Pubitemid 30489922)
52. Turner, N. A., (2011) Therapeutic regulation of cardiac fibroblast function: targeting stress-activated protein kinase pathways. Fut. Cardiol. 7, 673-691.
53. Xie, S., Nie, R., Wang, J., Li, F., and, Yuan, W., (2009) Transcription factor decoys for activator protein-1 (AP-1) inhibit oxidative stress-induced proliferation and matrix metalloproteinases in rat cardiac fibroblasts. Transl. Res. 153, 17-23.
54. Turner, N. A., (2011) Therapeutic strategies for targeting the cardiac fibroblast. In The Cardiac Fibroblast (Turner, N. A., ed.). pp. 273-285, Research Signpost, Kerala, India.